c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation

27Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

In many patients without clinical metastases, cancer cells have already escaped from the primary tumor and entered a distant organ. A long-standing question in metastasis research is why some disseminated cancer cells fail to complete steps of metastatic colonization for extended periods of time. Our laboratory identified c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4 (JNKK1/MKK4) as a metastasis suppressor protein in a mouse xenograft model of experimental i.p. ovarian cancer metastasis. In this model, expression of JNKK1/MKK4 via activation of p38 delays formation of ≥1-mm implants and prolongs animal survival. Here, we elucidate the time course of this delay as well as the biological mechanisms underpinning it. Using the Gompertz function to model the net accumulation of experimental omental metastases, we show that MKK4-expressing implants arise, on average, 30 days later than controls. Quantitative real-time PCR shows that MKK4 expression does not have a substantial effect on the number of cancer cells initially adhering to the omentum, and terminal deoxyribonucleotidyl transferase-mediated dUTP nick end labeling analysis shows that there is no increase in apoptosis in these cells. Instead, immunohistochemical quantitation of cell cycle proteins reveals that MKK4-expressing cells fail to proliferate once they reach the omentum and up-regulate p21, a cell cycle inhibitor. Consistent with the time course data, in vitro kinase assays and in vivo passaging of cell lines derived from macroscopic metastases show that the eventual outgrowth of MKK4-expressing cells is not due to a discrete selection event. Rather, the population of MKK4-expressing cells eventually uniformly adapts to the consequences of up-regulated MKK4 signaling. ©2008 American Association for Cancer Research.

References Powered by Scopus

WAF1, a potential mediator of p53 tumor suppression

8276Citations
N/AReaders
Get full text

Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions

3753Citations
N/AReaders
Get full text

P21 is a universal inhibitor of cyclin kinases

3333Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Cancer dormancy: A model of early dissemination and late cancer recurrence

178Citations
N/AReaders
Get full text

Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies

129Citations
N/AReaders
Get full text

Metastasis suppressor genes. At the interface between the environment and tumor cell growth

119Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lotan, T., Hickson, J., Souris, J., Huo, D., Taylor, J., Li, T., … Rinker-Schaeffer, C. W. (2008). c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation. Cancer Research, 68(7), 2166–2175. https://doi.org/10.1158/0008-5472.CAN-07-1568

Readers over time

‘11‘12‘13‘14‘15‘17‘18‘19‘20‘22‘2400.751.52.253

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

58%

Professor / Associate Prof. 3

25%

Researcher 2

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 6

38%

Agricultural and Biological Sciences 5

31%

Biochemistry, Genetics and Molecular Bi... 4

25%

Materials Science 1

6%

Save time finding and organizing research with Mendeley

Sign up for free
0